Arkolith/Insider Trading/ADIL/Form 4

Johnson Bankole A.

Chief Medical OfficerADIAL PHARMACEUTICALS, INC. (ADIL) · full profile →Form 4 · filed Oct 6, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 4, 2021Sell(S)200K——148K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 4, 2021Other(J)150K——40K

Transaction Codes

S
Open-market sale
J
Other acquisition / disposition

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-21-051646) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML